Daniel P Lew Selected Research

Culture Diffusion Chambers

7/2009	Comparison of tigecycline and vancomycin for treatment of experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus.
4/2006	Evaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infection.
9/2005	Intensive therapy with ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
8/2004	Modulation of fibronectin adhesins and other virulence factors in a teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.
7/2003	Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureus.
3/2003	Lack of biofilm contribution to bacterial colonisation in an experimental model of foreign body infection by Staphylococcus aureus and Staphylococcus epidermidis.
5/2002	Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel P Lew Research Topics

Disease

13	Infections 07/2009 - 05/2002
7	Foreign Bodies (Foreign Body) 07/2009 - 05/2002
2	Sepsis (Septicemia) 03/2012 - 04/2006
2	Diabetic Foot 06/2006 - 07/2004
2	Osteomyelitis 06/2006 - 07/2004
2	Staphylococcal Infections 05/2006 - 11/2004
1	Community-Acquired Infections 07/2012
1	Reinfection 03/2012
1	Septic Shock (Toxic Shock Syndrome) 11/2010
1	Autolysis 09/2006
1	Gangrene 06/2006
1	Ischemia 06/2006
1	Wounds and Injuries (Trauma) 06/2006
1	Ulcer 06/2006
1	Bacteremia 11/2004
1	Osteonecrosis (Kienbock's Disease) 07/2004
1	Communicable Diseases (Infectious Diseases) 07/2004
1	Candidemia 12/2002
1	Candidiasis (Moniliasis) 12/2002
1	Body Weight (Weight, Body) 05/2002

Drug/Important Bio-Agent (IBA)

8	Vancomycin FDA LinkGeneric 07/2012 - 05/2002
4	TeicoplaninIBA 07/2012 - 08/2004
3	GlycopeptidesIBA 07/2012 - 05/2006
3	Anti-Bacterial Agents (Antibiotics)IBA 06/2006 - 07/2004
2	Penicillins (Penicillin)FDA Link 07/2012 - 05/2006
2	Staphylococcus aureus RNAIIIIBA 11/2010 - 09/2006
2	Daptomycin FDA Link 04/2006 - 07/2003
2	ProdrugsIBA 09/2005 - 05/2002
2	FluoroquinolonesIBA 11/2004 - 05/2002
1	SuperantigensIBA 11/2010
1	Methicillin (Metin)FDA Link 07/2009
1	Tigecycline (Tygacil)FDA Link 07/2009
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 06/2006
1	Cephalosporins (Cephalosporin Antibiotics)IBA 05/2006
1	Anti-Infective Agents (Microbicides)IBA 05/2006
1	Oxacillin (Prostaphlin)FDA LinkGeneric 04/2006
1	ceftobiproleIBA 09/2005
1	ceftobiprole medocarilIBA 09/2005
1	Rifampin (Rifampicin)FDA LinkGeneric 11/2004
1	CoagulaseIBA 11/2004
1	Pharmaceutical PreparationsIBA 11/2004
1	Floxacillin (Flucloxacillin)IBA 11/2004
1	FleroxacinIBA 11/2004
1	Carrier Proteins (Binding Protein)IBA 08/2004
1	Fibronectins (Fibronectin)IBA 08/2004
1	Fluconazole (Zonal)FDA LinkGeneric 12/2002
1	Glucose (Dextrose)FDA LinkGeneric 07/2002
1	trovafloxacinIBA 05/2002
1	Levofloxacin (Levaquin)FDA Link 05/2002
1	alatrofloxacin (Trovan)FDA Link 05/2002
1	QuinolonesIBA 05/2002

Therapy/Procedure

8	Therapeutics 06/2006 - 05/2002
7	Culture Diffusion Chambers 07/2009 - 05/2002
2	Debridement 06/2006 - 07/2004
2	Catheters 04/2006 - 11/2004
1	Curettage 06/2006
1	Hyperbaric Oxygenation 06/2006
1	Surgical Amputation (Amputations) 06/2006
1	Orthopedic Procedures 05/2006
1	Length of Stay 11/2004
1	Joint Prosthesis 07/2004
1	Vascular Surgical Procedures 07/2004